Technical Analysis for HEB - Hemispherx BioPharma, Inc.

Grade Last Price % Change Price Change
grade F 0.172 0.17% 0.00
HEB closed up 0.17 percent on Tuesday, March 19, 2019, on 1.11 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Earnings due: Apr 1

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical HEB trend table...

Date Alert Name Type % Chg
Mar 19 Narrow Range Bar Range Contraction 0.00%
Mar 19 NR7 Range Contraction 0.00%
Mar 19 Inside Day Range Contraction 0.00%
Mar 19 Wide Bands Range Expansion 0.00%
Mar 18 MACD Bullish Signal Line Cross Bullish 0.17%
Mar 18 Wide Bands Range Expansion 0.17%
Mar 15 NR7 Range Contraction 1.18%
Mar 15 Wide Bands Range Expansion 1.18%
Mar 14 Wide Bands Range Expansion 1.18%
Mar 14 Oversold Stochastic Weakness 1.18%

Older signals for HEB ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Its products include Ampligen, which is under clinical development for the treatment of Chronic Fatigue Syndrome, Hepatitis B, human immunodeficiency virus (HIV), renal cell carcinoma, and malignant melanoma; Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, a low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza and other emerging viral diseases. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.
Medicine Medical Specialties Pharmaceutical Alpha Infectious Diseases Influenza HIV Hepatitis B Drug Therapies Renal Cell Carcinoma Viral Diseases Antivirals Interferon Chronic Disorders
Is HEB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.515
52 Week Low 0.1495
Average Volume 500,637
200-Day Moving Average 0.2413
50-Day Moving Average 0.2096
20-Day Moving Average 0.1803
10-Day Moving Average 0.1682
Average True Range 0.0182
ADX 37.71
+DI 11.649
-DI 22.3534
Chandelier Exit (Long, 3 ATRs ) 0.1954
Chandelier Exit (Short, 3 ATRs ) 0.2041
Upper Bollinger Band 0.216
Lower Bollinger Band 0.1446
Percent B (%b) 0.38
BandWidth 39.600666
MACD Line -0.0129
MACD Signal Line -0.0136
MACD Histogram 0.0007
Fundamentals Value
Market Cap 5.02 Million
Num Shares 29.2 Million
EPS -0.37
Price-to-Earnings (P/E) Ratio -0.47
Price-to-Sales 27.86
Price-to-Book 0.90
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.19
Resistance 3 (R3) 0.19 0.18 0.18
Resistance 2 (R2) 0.18 0.18 0.18 0.18
Resistance 1 (R1) 0.18 0.18 0.18 0.18 0.18
Pivot Point 0.17 0.17 0.18 0.17 0.17
Support 1 (S1) 0.17 0.17 0.17 0.17 0.16
Support 2 (S2) 0.16 0.17 0.16 0.16
Support 3 (S3) 0.16 0.16 0.16
Support 4 (S4) 0.16